Comprehensive pan‑cancer analysis of MTDH for human tumor prognosis and as an immunological biomarker including breast and kidney cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comprehensive pan‑cancer analysis of MTDH for human tumor prognosis and as an immunological biomarker including breast and kidney cancer

Published:2024-06-03 Issue:2 Volume:28 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Yang Lixian¹,Han Mingqiang²,Zhao Xiaoling³,Zheng Lei¹,Kong Fanting¹,Zhang Shiyu¹,Jia Lining¹,Li Xiaowei¹,Wang Meng¹

Affiliation:

1. Department of Breast Surgery, Xingtai People's Hospital, Xingtai, Hebei 054001, P.R. China

2. Department of Thyroid Surgery, Xingtai People's Hospital, Xingtai, Hebei 054001, P.R. China

3. Oncology Laboratory, Xingtai People's Hospital, Xingtai, Hebei 054001, P.R. China

Publisher

Spandidos Publications

Reference51 articles.

1. Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): A population-based study;Arnold;Lancet Oncol,2019

2. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer;Bindea;Immunity,2013

3. Neoantigens in cancer immunotherapy;Schumacher;Science,2015

4. Immune checkpoint blockade: A common denominator approach to cancer therapy;Topalian;Cancer Cell,2015

5. Cancer immune contexture and immunotherapy;Becht;Curr Opin Immunol,2016

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP